- Home
- FENC vs PACH Comparison
FENC vs PACH Comparison
Compare FENC & PACH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$7.57
Company Overview
Basic Information| Metric | FENC | PACH |
|---|---|---|
| Founded | 1996 | 2024 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 276.3M | 319.4M |
| IPO Year | 2001 | 2025 |
Fundamental Metrics
Financial Performance| Metric | FENC | PACH |
|---|---|---|
| Price | $7.57 | $10.09 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $15.00 | N/A |
| AVG Volume (30 Days) | ★ 179.1K | 19.7K |
| Earning Date | 03-09-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $38,790,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $70.97 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.68 | $9.94 |
| 52 Week High | $9.92 | $10.16 |
Technical Indicators
Market Signals| Indicator | FENC | PACH |
|---|---|---|
| Relative Strength Index (RSI) | 48.02 | N/A |
| Support Level | $7.35 | N/A |
| Resistance Level | $7.82 | N/A |
| Average True Range (ATR) | 0.39 | 0.00 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 31.06 | 0.00 |
Price Performance
Historical Comparison FENC
PACH
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
About PACH Pioneer Acquisition I Corp Class A Ordinary Shares
Pioneer Acquisition I Corp is a blank check company.